LTRN - Lantern Pharma Inc.
4.34
0.530 12.212%
Share volume: 145,110
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$3.81
0.53
0.14%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 03-27-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | |||
| Operating expenses | 5.732 M | 5.408 M | 5.180 M | 5.896 M | |
| Selling general and admin | 1.481 M | 1.520 M | 1.463 M | 1.627 M | |
| Research and development | 4.251 M | 3.889 M | 3.717 M | 4.270 M | |
| Total expenses | 5.732 M | 5.408 M | 5.180 M | 5.896 M | |
| -5.64% | -4.23% | 13.84% | |||
| Operating income | -5.732 M | -5.408 M | -5.180 M | -5.896 M | |
| Ebit | -5.642 M | -5.148 M | -4.697 M | -6.037 M | |
| Pretax income | -5.441 M | -4.960 M | -4.506 M | -5.875 M | |
| -8.85% | -9.15% | 30.39% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -5.441 M | -4.960 M | -4.506 M | -5.875 M | |
| 8.85% | 9.15% | -30.39% |
